Paul Ehrlich and O.T. Avery: pathfinders in the search for immunity
This paper is concerned with the use of passive immunity for the prevention and treatment of infections from a historic perspective, particularly in regard to the research of Paul Ehrlich on diphtheria and that of O.T. Avery on pneumonia. It is timely to reexamine this matter, particularly in regard...
Gespeichert in:
| Veröffentlicht in: | Vaccine 1999-10, Vol.17, p.S64-S67 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S67 |
|---|---|
| container_issue | |
| container_start_page | S64 |
| container_title | Vaccine |
| container_volume | 17 |
| creator | Krause, Richard M. |
| description | This paper is concerned with the use of passive immunity for the prevention and treatment of infections from a historic perspective, particularly in regard to the research of Paul Ehrlich on diphtheria and that of O.T. Avery on pneumonia. It is timely to reexamine this matter, particularly in regard to virus infections, in view of the difficulties in developing antiviral drugs. In addition, specific antibodies can serve as an alternative therapy for antibiotic resistant microbes.
It is worth recalling in the history of vaccine development that success in passive immunity has been the key element in devising a successful strategy to develop a vaccine to produce humoral immunity. |
| doi_str_mv | 10.1016/S0264-410X(99)00296-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69276322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0264410X99002960</els_id><sourcerecordid>69276322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c361t-a3eaaa5a441f46c126575dd558172264b9a66f5b195b0ad0e5af6a6caa3f51d03</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMotlZ_gpKT6GFrsrtJGy9SSv2AQgUreAvTZJZG9qMmu4X-e7ddEW-e5vLM-848hFxyNuSMy7s3Fss0Sjn7uFHqlrFYyYgdkT4fj5IoFnx8TPq_SI-chfDJGBMJV6ekx5kQSiTjPpm-QpPT2drnzqwplJYuhsshnWzR7-7pBup15kqLPlBX0nqNNCD4lswqT11RNKWrd-fkJIM84MXPHJD3x9ly-hzNF08v08k8MonkdQQJAoCANOVZKg2PpRgJa4UY81HcXrpSIGUmVlyJFQPLUEAmQRqAJBPcsmRArrvcja--Ggy1LlwwmOdQYtUELVU8kkkct6DoQOOrEDxmeuNdAX6nOdN7e_pgT-_VaKX0wZ7eF1z9FDSrAu2frU5XCzx0ALZvbh16HYzD0qB1Hk2tbeX-qfgGsIJ-EQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69276322</pqid></control><display><type>article</type><title>Paul Ehrlich and O.T. Avery: pathfinders in the search for immunity</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Krause, Richard M.</creator><creatorcontrib>Krause, Richard M.</creatorcontrib><description>This paper is concerned with the use of passive immunity for the prevention and treatment of infections from a historic perspective, particularly in regard to the research of Paul Ehrlich on diphtheria and that of O.T. Avery on pneumonia. It is timely to reexamine this matter, particularly in regard to virus infections, in view of the difficulties in developing antiviral drugs. In addition, specific antibodies can serve as an alternative therapy for antibiotic resistant microbes.
It is worth recalling in the history of vaccine development that success in passive immunity has been the key element in devising a successful strategy to develop a vaccine to produce humoral immunity.</description><identifier>ISSN: 0264-410X</identifier><identifier>EISSN: 1873-2518</identifier><identifier>DOI: 10.1016/S0264-410X(99)00296-0</identifier><identifier>PMID: 10559538</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>History of medicine ; History, 20th Century ; Humans ; Immunization, Passive - history ; Pneumonia, Pneumococcal - therapy</subject><ispartof>Vaccine, 1999-10, Vol.17, p.S64-S67</ispartof><rights>1999 Elsevier Science Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c361t-a3eaaa5a441f46c126575dd558172264b9a66f5b195b0ad0e5af6a6caa3f51d03</citedby><cites>FETCH-LOGICAL-c361t-a3eaaa5a441f46c126575dd558172264b9a66f5b195b0ad0e5af6a6caa3f51d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0264-410X(99)00296-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10559538$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krause, Richard M.</creatorcontrib><title>Paul Ehrlich and O.T. Avery: pathfinders in the search for immunity</title><title>Vaccine</title><addtitle>Vaccine</addtitle><description>This paper is concerned with the use of passive immunity for the prevention and treatment of infections from a historic perspective, particularly in regard to the research of Paul Ehrlich on diphtheria and that of O.T. Avery on pneumonia. It is timely to reexamine this matter, particularly in regard to virus infections, in view of the difficulties in developing antiviral drugs. In addition, specific antibodies can serve as an alternative therapy for antibiotic resistant microbes.
It is worth recalling in the history of vaccine development that success in passive immunity has been the key element in devising a successful strategy to develop a vaccine to produce humoral immunity.</description><subject>History of medicine</subject><subject>History, 20th Century</subject><subject>Humans</subject><subject>Immunization, Passive - history</subject><subject>Pneumonia, Pneumococcal - therapy</subject><issn>0264-410X</issn><issn>1873-2518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMotlZ_gpKT6GFrsrtJGy9SSv2AQgUreAvTZJZG9qMmu4X-e7ddEW-e5vLM-848hFxyNuSMy7s3Fss0Sjn7uFHqlrFYyYgdkT4fj5IoFnx8TPq_SI-chfDJGBMJV6ekx5kQSiTjPpm-QpPT2drnzqwplJYuhsshnWzR7-7pBup15kqLPlBX0nqNNCD4lswqT11RNKWrd-fkJIM84MXPHJD3x9ly-hzNF08v08k8MonkdQQJAoCANOVZKg2PpRgJa4UY81HcXrpSIGUmVlyJFQPLUEAmQRqAJBPcsmRArrvcja--Ggy1LlwwmOdQYtUELVU8kkkct6DoQOOrEDxmeuNdAX6nOdN7e_pgT-_VaKX0wZ7eF1z9FDSrAu2frU5XCzx0ALZvbh16HYzD0qB1Hk2tbeX-qfgGsIJ-EQ</recordid><startdate>19991029</startdate><enddate>19991029</enddate><creator>Krause, Richard M.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991029</creationdate><title>Paul Ehrlich and O.T. Avery: pathfinders in the search for immunity</title><author>Krause, Richard M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c361t-a3eaaa5a441f46c126575dd558172264b9a66f5b195b0ad0e5af6a6caa3f51d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>History of medicine</topic><topic>History, 20th Century</topic><topic>Humans</topic><topic>Immunization, Passive - history</topic><topic>Pneumonia, Pneumococcal - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krause, Richard M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Vaccine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krause, Richard M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Paul Ehrlich and O.T. Avery: pathfinders in the search for immunity</atitle><jtitle>Vaccine</jtitle><addtitle>Vaccine</addtitle><date>1999-10-29</date><risdate>1999</risdate><volume>17</volume><spage>S64</spage><epage>S67</epage><pages>S64-S67</pages><issn>0264-410X</issn><eissn>1873-2518</eissn><abstract>This paper is concerned with the use of passive immunity for the prevention and treatment of infections from a historic perspective, particularly in regard to the research of Paul Ehrlich on diphtheria and that of O.T. Avery on pneumonia. It is timely to reexamine this matter, particularly in regard to virus infections, in view of the difficulties in developing antiviral drugs. In addition, specific antibodies can serve as an alternative therapy for antibiotic resistant microbes.
It is worth recalling in the history of vaccine development that success in passive immunity has been the key element in devising a successful strategy to develop a vaccine to produce humoral immunity.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>10559538</pmid><doi>10.1016/S0264-410X(99)00296-0</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0264-410X |
| ispartof | Vaccine, 1999-10, Vol.17, p.S64-S67 |
| issn | 0264-410X 1873-2518 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69276322 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | History of medicine History, 20th Century Humans Immunization, Passive - history Pneumonia, Pneumococcal - therapy |
| title | Paul Ehrlich and O.T. Avery: pathfinders in the search for immunity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T02%3A30%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Paul%20Ehrlich%20and%20O.T.%20Avery:%20pathfinders%20in%20the%20search%20for%20immunity&rft.jtitle=Vaccine&rft.au=Krause,%20Richard%20M.&rft.date=1999-10-29&rft.volume=17&rft.spage=S64&rft.epage=S67&rft.pages=S64-S67&rft.issn=0264-410X&rft.eissn=1873-2518&rft_id=info:doi/10.1016/S0264-410X(99)00296-0&rft_dat=%3Cproquest_cross%3E69276322%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69276322&rft_id=info:pmid/10559538&rft_els_id=S0264410X99002960&rfr_iscdi=true |